Display Settings:

Format

Send to:

Choose Destination

    Acta Oncol. 1997;36(1):45-50.

    Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients.

    Harbo G, Grau C, Bundgaard T, Overgaard M, Elbrønd O, Søgaard H, Overgaard J.

    Department of Head & Neck Surgery, Aarhus University Hospital, Denmark.

    In the period 1963-1991, a total of 277 consecutive patients with malignant tumours of the nasal cavity and paranasal sinuses were treated at Aarhus University Hospital. The major histological types included squamous cell carcinoma (46%), lymphoma (14%), adenocarcinoma (13%), and malignant melanoma (9%). Kaplan-Meier estimates of 5-year corrected survival (death from cancer) showed the best prognosis for adenoid cystic carcinoma (87%), adenocarcinoma (65%) and lymphoma (56%), and the poorest prognosis for undifferentiated carcinoma (17%) and malignant melanoma (24%). The 5-year corrected survival for squamous cell carcinoma was 35%. Of the 180 patients with treatment failure, the vast majority occurred locally (n = 166); a minor proportion was regional (n = 23) or distant (n = 30). For the 195 patients with carcinoma, the following parameters were of statistical prognostic significance (5-year corrected survival): histological differentiation (moderate-well 65% vs. poor 22%), primary T-site (nasal cavity 56% vs. maxillary antrum 39% vs. other sinuses 24%), tumour stage (T2 68% vs. T3 37% vs. T4 29%), nodal stage (N0 48% vs. N1-3 21%), treatment (radiotherapy + surgery 56% vs. radiation alone 35%).

    PMID: 9090965 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read